Review



3d model visualization software ctvol v2 3 2 0  (Bruker Corporation)


Bioz Verified Symbol Bruker Corporation is a verified supplier
Bioz Manufacturer Symbol Bruker Corporation manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 99

    Structured Review

    Bruker Corporation 3d model visualization software ctvol v2 3 2 0
    3d Model Visualization Software Ctvol V2 3 2 0, supplied by Bruker Corporation, used in various techniques. Bioz Stars score: 99/100, based on 10599 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/micro-ct+3d+visualization+software/Micro-CT/pm42162236-48-16-22
    Average 99 stars, based on 10599 article reviews
    3d model visualization software ctvol v2 3 2 0 - by Bioz Stars, 2026-10
    99/100 stars

    Images

    Related Articles

    Software:

    Article Title: Scalable 4D biofabrication process for the manufacture of scaffold-free bone-forming callus implants.
    Article Snippet: All surgical procedures were conducted according to protocols approved by the KU Leuven Ethical Committee (approval number 222/2023) Nano-CT Mineralized explant’s compartments were analyzed using nano-CT (Phoenix Nanotom M, GE Measurement, and Control Solutions) with the following parameters: 0.2 mm aluminum filter, diamond target, exposure time 500 ms, skip image 0, 2400 images, 60 kV voltage, 170 μA current, voxel size of 4.5 μm and mode fast scan with focal spot size 2.42. .. Image processing and quantification were assessed wi th CTAn software (Bruker micro-CT, BE), while for the 3D visualization, CTvox (Bruker micro-CT, BE) software was used. ..

    Article Title: Co-administration of calcium carbonate or sodium bicarbonate prevents esomeprazole-induced osteoporosis.
    Article Snippet: Three-dimensional (3D) reconstruction was performed using Nrecon v1.7.3.1 software (Bruker Micro-CT) and InstaRecon software ACCEPTED MANUSCRIPT AR TIC LE IN PR ES S ARTICLE IN PRESS (InstaRecon, Champaigne, IL, USA). .. Data analysis was performed using CTAn v1.20.3.0 software (Bruker Micro-CT), and visualization was performed using the 3D model visualization software CTVol v2.3.2.0 (Bruker Micro-CT). ..

    Micro-CT:

    Article Title: Scalable 4D biofabrication process for the manufacture of scaffold-free bone-forming callus implants.
    Article Snippet: All surgical procedures were conducted according to protocols approved by the KU Leuven Ethical Committee (approval number 222/2023) Nano-CT Mineralized explant’s compartments were analyzed using nano-CT (Phoenix Nanotom M, GE Measurement, and Control Solutions) with the following parameters: 0.2 mm aluminum filter, diamond target, exposure time 500 ms, skip image 0, 2400 images, 60 kV voltage, 170 μA current, voxel size of 4.5 μm and mode fast scan with focal spot size 2.42. .. Image processing and quantification were assessed wi th CTAn software (Bruker micro-CT, BE), while for the 3D visualization, CTvox (Bruker micro-CT, BE) software was used. ..

    Article Title: Co-administration of calcium carbonate or sodium bicarbonate prevents esomeprazole-induced osteoporosis.
    Article Snippet: Three-dimensional (3D) reconstruction was performed using Nrecon v1.7.3.1 software (Bruker Micro-CT) and InstaRecon software ACCEPTED MANUSCRIPT AR TIC LE IN PR ES S ARTICLE IN PRESS (InstaRecon, Champaigne, IL, USA). .. Data analysis was performed using CTAn v1.20.3.0 software (Bruker Micro-CT), and visualization was performed using the 3D model visualization software CTVol v2.3.2.0 (Bruker Micro-CT). ..

    Analysis:

    Article Title: Co-administration of calcium carbonate or sodium bicarbonate prevents esomeprazole-induced osteoporosis.
    Article Snippet: Three-dimensional (3D) reconstruction was performed using Nrecon v1.7.3.1 software (Bruker Micro-CT) and InstaRecon software ACCEPTED MANUSCRIPT AR TIC LE IN PR ES S ARTICLE IN PRESS (InstaRecon, Champaigne, IL, USA). .. Data analysis was performed using CTAn v1.20.3.0 software (Bruker Micro-CT), and visualization was performed using the 3D model visualization software CTVol v2.3.2.0 (Bruker Micro-CT). ..

    other:

    Article Title: An orally-administered nanotherapeutics with gold nanospheres supplying for rheumatoid arthritis therapy by re-shaping gut microbial tryptophan metabolism.
    Article Snippet: Additionally, 3D morphological analysis was conducted using CTvox 3D-model visualization software (Bruker Micro-CT, Ver.



    Similar Products

    99
    Bruker Corporation 3d model visualization software ctvol v2 3 2 0
    3d Model Visualization Software Ctvol V2 3 2 0, supplied by Bruker Corporation, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/micro-ct+3d+visualization+software/Micro-CT/pm42162236-48-16-22
    Average 99 stars, based on 1 article reviews
    3d model visualization software ctvol v2 3 2 0 - by Bioz Stars, 2026-10
    99/100 stars
      Buy from Supplier

    90
    Bruker Corporation 3d visualization software ctvol micro-ct
    3d Visualization Software Ctvol Micro Ct, supplied by Bruker Corporation, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/micro-ct+3d+visualization+software/3d+model+visualisation+software+bruker+micro+ct/pm40543083-188-1-5
    Average 90 stars, based on 1 article reviews
    3d visualization software ctvol micro-ct - by Bioz Stars, 2026-10
    90/100 stars
      Buy from Supplier

    90
    Micro Photonics Inc micro-ct 3d visualization software
    Micro Ct 3d Visualization Software, supplied by Micro Photonics Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/micro-ct+3d+visualization+software/micro+ct+3d+visualization+software/10__1016_slash_j__mtbio__2024__101353-359-0-4
    Average 90 stars, based on 1 article reviews
    micro-ct 3d visualization software - by Bioz Stars, 2026-10
    90/100 stars
      Buy from Supplier

    99
    Bruker Corporation realistic 3d visualization software
    Realistic 3d Visualization Software, supplied by Bruker Corporation, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/micro-ct+3d+visualization+software/Micro-CT/10__1007_slash_s12274___024___6656___8-130-9-12
    Average 99 stars, based on 1 article reviews
    realistic 3d visualization software - by Bioz Stars, 2026-10
    99/100 stars
      Buy from Supplier

    99
    Bruker Corporation 3d model visualization software
    Fig. 2 GNPs treatment alleviated ACLT-induced OA. (A) To evaluate the mitigation of GNPs on OA, C57BL/6J mice (6–8 weeks, male, 20–25 g) were selected to undergo anterior cruciate ligament transection surgery to induce the OA models, and randomly assigned to ACLTVehicle or ACLTGNPs group. The ACLTVehicle and ACLTGNPs groups were given continuous gavage with the equivalent amount of saline and GNPs for 8 weeks, respectively. (B) H&E, Safranine O and Toluidine Blue staining of femur articular cartilage in ACLTVehicle and ACLTGNPs groups. (C) Immunohistochemical staining of the expres sion of MMP-13 in articular cartilage of sections. (D) Immunohistochemical staining of the expression of Aggrecan in articular cartilage of sections. (E) Quantitative analysis of Osteoarthritis Research Society International (OARSI) histology scoring. (F) Quantitative analysis of MANKIN grading. (G) Quantita tive analysis of percentage of cells with positive staining for MMP-13 in articular cartilage. (H) Quantitative analysis of percentage of cells with positive staining for Aggrecan in articular cartilage. (I) Representative µCT images about 2D images of longitudinal section femurs and <t>3D</t> images of distal femur. The coloring parts represent the regions of interest (ROI) for analysis. Quantification of femoral BMD, BV/TV, Tb.Th, Tb.N and Tb.Sp in indicated groups, n = 7. (J) Representative µCT images about 2D images of longitudinal section tibias and 3D images <t>of</t> <t>proximal</t> tibias. The coloring parts represent the ROI for analysis. Quantification of tibial BMD, BV/TV, Tb.Th, Tb.N and Tb.Sp in indicated groups, n = 7. (K) Representative images of IF staining of TRAP in the subchondral bone of the ACLTVehicle and ACLTGNPs mice. (L) Representative images of IF staining of Netrin-1 in the subchondral bone of the ACLTVehicle and ACLTGNPs mice. (M) Representative images of IF staining of CGRP+ fibers in the subchondral bone of the ACLTVehicle and ACLTGNPs mice. (N) Quantitative analysis of TRAP staining. (O) Quantitative analysis of Netrin-1staining. (P) Quantitative analysis of CGRP+ fibers staining. (*p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001, N.S represented not significant)
    3d Model Visualization Software, supplied by Bruker Corporation, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/micro-ct+3d+visualization+software/Micro-CT/pm38589904-105-20-25
    Average 99 stars, based on 1 article reviews
    3d model visualization software - by Bioz Stars, 2026-10
    99/100 stars
      Buy from Supplier

    90
    Skyscan Corporation dataviewer 2d/3d micro-ct slice visualization software
    Fig. 2 GNPs treatment alleviated ACLT-induced OA. (A) To evaluate the mitigation of GNPs on OA, C57BL/6J mice (6–8 weeks, male, 20–25 g) were selected to undergo anterior cruciate ligament transection surgery to induce the OA models, and randomly assigned to ACLTVehicle or ACLTGNPs group. The ACLTVehicle and ACLTGNPs groups were given continuous gavage with the equivalent amount of saline and GNPs for 8 weeks, respectively. (B) H&E, Safranine O and Toluidine Blue staining of femur articular cartilage in ACLTVehicle and ACLTGNPs groups. (C) Immunohistochemical staining of the expres sion of MMP-13 in articular cartilage of sections. (D) Immunohistochemical staining of the expression of Aggrecan in articular cartilage of sections. (E) Quantitative analysis of Osteoarthritis Research Society International (OARSI) histology scoring. (F) Quantitative analysis of MANKIN grading. (G) Quantita tive analysis of percentage of cells with positive staining for MMP-13 in articular cartilage. (H) Quantitative analysis of percentage of cells with positive staining for Aggrecan in articular cartilage. (I) Representative µCT images about 2D images of longitudinal section femurs and <t>3D</t> images of distal femur. The coloring parts represent the regions of interest (ROI) for analysis. Quantification of femoral BMD, BV/TV, Tb.Th, Tb.N and Tb.Sp in indicated groups, n = 7. (J) Representative µCT images about 2D images of longitudinal section tibias and 3D images <t>of</t> <t>proximal</t> tibias. The coloring parts represent the ROI for analysis. Quantification of tibial BMD, BV/TV, Tb.Th, Tb.N and Tb.Sp in indicated groups, n = 7. (K) Representative images of IF staining of TRAP in the subchondral bone of the ACLTVehicle and ACLTGNPs mice. (L) Representative images of IF staining of Netrin-1 in the subchondral bone of the ACLTVehicle and ACLTGNPs mice. (M) Representative images of IF staining of CGRP+ fibers in the subchondral bone of the ACLTVehicle and ACLTGNPs mice. (N) Quantitative analysis of TRAP staining. (O) Quantitative analysis of Netrin-1staining. (P) Quantitative analysis of CGRP+ fibers staining. (*p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001, N.S represented not significant)
    Dataviewer 2d/3d Micro Ct Slice Visualization Software, supplied by Skyscan Corporation, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/micro-ct+3d+visualization+software/dataviewer+2d+3d+micro+ct+slice+visualization+software/10__1016_slash_j__carbon__2021__05__003-138-12-22
    Average 90 stars, based on 1 article reviews
    dataviewer 2d/3d micro-ct slice visualization software - by Bioz Stars, 2026-10
    90/100 stars
      Buy from Supplier

    86
    Skyscan Corporation dataviewer 2d 3d micro ct slice visualization software
    Fig. 2 GNPs treatment alleviated ACLT-induced OA. (A) To evaluate the mitigation of GNPs on OA, C57BL/6J mice (6–8 weeks, male, 20–25 g) were selected to undergo anterior cruciate ligament transection surgery to induce the OA models, and randomly assigned to ACLTVehicle or ACLTGNPs group. The ACLTVehicle and ACLTGNPs groups were given continuous gavage with the equivalent amount of saline and GNPs for 8 weeks, respectively. (B) H&E, Safranine O and Toluidine Blue staining of femur articular cartilage in ACLTVehicle and ACLTGNPs groups. (C) Immunohistochemical staining of the expres sion of MMP-13 in articular cartilage of sections. (D) Immunohistochemical staining of the expression of Aggrecan in articular cartilage of sections. (E) Quantitative analysis of Osteoarthritis Research Society International (OARSI) histology scoring. (F) Quantitative analysis of MANKIN grading. (G) Quantita tive analysis of percentage of cells with positive staining for MMP-13 in articular cartilage. (H) Quantitative analysis of percentage of cells with positive staining for Aggrecan in articular cartilage. (I) Representative µCT images about 2D images of longitudinal section femurs and <t>3D</t> images of distal femur. The coloring parts represent the regions of interest (ROI) for analysis. Quantification of femoral BMD, BV/TV, Tb.Th, Tb.N and Tb.Sp in indicated groups, n = 7. (J) Representative µCT images about 2D images of longitudinal section tibias and 3D images <t>of</t> <t>proximal</t> tibias. The coloring parts represent the ROI for analysis. Quantification of tibial BMD, BV/TV, Tb.Th, Tb.N and Tb.Sp in indicated groups, n = 7. (K) Representative images of IF staining of TRAP in the subchondral bone of the ACLTVehicle and ACLTGNPs mice. (L) Representative images of IF staining of Netrin-1 in the subchondral bone of the ACLTVehicle and ACLTGNPs mice. (M) Representative images of IF staining of CGRP+ fibers in the subchondral bone of the ACLTVehicle and ACLTGNPs mice. (N) Quantitative analysis of TRAP staining. (O) Quantitative analysis of Netrin-1staining. (P) Quantitative analysis of CGRP+ fibers staining. (*p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001, N.S represented not significant)
    Dataviewer 2d 3d Micro Ct Slice Visualization Software, supplied by Skyscan Corporation, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/micro-ct+3d+visualization+software/2d+3d+ct+dataviewer+micro+slice+software+visualization/pmc08262818-152-11-17
    Average 86 stars, based on 1 article reviews
    dataviewer 2d 3d micro ct slice visualization software - by Bioz Stars, 2026-10
    86/100 stars
      Buy from Supplier

    Image Search Results


    Fig. 2 GNPs treatment alleviated ACLT-induced OA. (A) To evaluate the mitigation of GNPs on OA, C57BL/6J mice (6–8 weeks, male, 20–25 g) were selected to undergo anterior cruciate ligament transection surgery to induce the OA models, and randomly assigned to ACLTVehicle or ACLTGNPs group. The ACLTVehicle and ACLTGNPs groups were given continuous gavage with the equivalent amount of saline and GNPs for 8 weeks, respectively. (B) H&E, Safranine O and Toluidine Blue staining of femur articular cartilage in ACLTVehicle and ACLTGNPs groups. (C) Immunohistochemical staining of the expres sion of MMP-13 in articular cartilage of sections. (D) Immunohistochemical staining of the expression of Aggrecan in articular cartilage of sections. (E) Quantitative analysis of Osteoarthritis Research Society International (OARSI) histology scoring. (F) Quantitative analysis of MANKIN grading. (G) Quantita tive analysis of percentage of cells with positive staining for MMP-13 in articular cartilage. (H) Quantitative analysis of percentage of cells with positive staining for Aggrecan in articular cartilage. (I) Representative µCT images about 2D images of longitudinal section femurs and 3D images of distal femur. The coloring parts represent the regions of interest (ROI) for analysis. Quantification of femoral BMD, BV/TV, Tb.Th, Tb.N and Tb.Sp in indicated groups, n = 7. (J) Representative µCT images about 2D images of longitudinal section tibias and 3D images of proximal tibias. The coloring parts represent the ROI for analysis. Quantification of tibial BMD, BV/TV, Tb.Th, Tb.N and Tb.Sp in indicated groups, n = 7. (K) Representative images of IF staining of TRAP in the subchondral bone of the ACLTVehicle and ACLTGNPs mice. (L) Representative images of IF staining of Netrin-1 in the subchondral bone of the ACLTVehicle and ACLTGNPs mice. (M) Representative images of IF staining of CGRP+ fibers in the subchondral bone of the ACLTVehicle and ACLTGNPs mice. (N) Quantitative analysis of TRAP staining. (O) Quantitative analysis of Netrin-1staining. (P) Quantitative analysis of CGRP+ fibers staining. (*p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001, N.S represented not significant)

    Journal: Journal of nanobiotechnology

    Article Title: Gold nanoparticles exhibit anti-osteoarthritic effects via modulating interaction of the "microbiota-gut-joint" axis.

    doi: 10.1186/s12951-024-02447-y

    Figure Lengend Snippet: Fig. 2 GNPs treatment alleviated ACLT-induced OA. (A) To evaluate the mitigation of GNPs on OA, C57BL/6J mice (6–8 weeks, male, 20–25 g) were selected to undergo anterior cruciate ligament transection surgery to induce the OA models, and randomly assigned to ACLTVehicle or ACLTGNPs group. The ACLTVehicle and ACLTGNPs groups were given continuous gavage with the equivalent amount of saline and GNPs for 8 weeks, respectively. (B) H&E, Safranine O and Toluidine Blue staining of femur articular cartilage in ACLTVehicle and ACLTGNPs groups. (C) Immunohistochemical staining of the expres sion of MMP-13 in articular cartilage of sections. (D) Immunohistochemical staining of the expression of Aggrecan in articular cartilage of sections. (E) Quantitative analysis of Osteoarthritis Research Society International (OARSI) histology scoring. (F) Quantitative analysis of MANKIN grading. (G) Quantita tive analysis of percentage of cells with positive staining for MMP-13 in articular cartilage. (H) Quantitative analysis of percentage of cells with positive staining for Aggrecan in articular cartilage. (I) Representative µCT images about 2D images of longitudinal section femurs and 3D images of distal femur. The coloring parts represent the regions of interest (ROI) for analysis. Quantification of femoral BMD, BV/TV, Tb.Th, Tb.N and Tb.Sp in indicated groups, n = 7. (J) Representative µCT images about 2D images of longitudinal section tibias and 3D images of proximal tibias. The coloring parts represent the ROI for analysis. Quantification of tibial BMD, BV/TV, Tb.Th, Tb.N and Tb.Sp in indicated groups, n = 7. (K) Representative images of IF staining of TRAP in the subchondral bone of the ACLTVehicle and ACLTGNPs mice. (L) Representative images of IF staining of Netrin-1 in the subchondral bone of the ACLTVehicle and ACLTGNPs mice. (M) Representative images of IF staining of CGRP+ fibers in the subchondral bone of the ACLTVehicle and ACLTGNPs mice. (N) Quantitative analysis of TRAP staining. (O) Quantitative analysis of Netrin-1staining. (P) Quantitative analysis of CGRP+ fibers staining. (*p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001, N.S represented not significant)

    Article Snippet: The subchondral bone regions of the distal femur and proximal tibia were selected as the region of interest (ROI), and 3D model visualization software (CTvox, Bruker micro-CT, ver.3.3.1.0) was used for 3-dimensional histomorphometric analysis.

    Techniques: Saline, Staining, Immunohistochemical staining, Expressing

    Fig. 3 The protective effect of GNPs against ACLT-induced OA disappeared after gut microbiota consumption. (A) The schematic diagram of gut micro biota consumption experiments. (B) H&E, Safranine O and Toluidine Blue staining of femur articular cartilage in ACLTVehicle+ABX and ACLTGNPs+ABX groups. (C) Immunohistochemical staining of the expression of MMP-13 in articular cartilage of sections. (D) Immunohistochemical staining of the expression of Ag grecan in articular cartilage of sections. (E) Quantitative analysis of OARSI histology scoring. (F) Quantitative analysis of MANKIN grading. (G) Quantitative analysis of percentage of cells with positive staining for MMP-13 in articular cartilage. (H) Quantitative analysis of percentage of cells with positive staining for Aggrecan in articular cartilage. (I) Representative µCT images about 2D images of longitudinal section femurs and 3D images of distal femurs. The col oring parts represent the ROI for analysis. Quantification of femoral BMD, BV/TV, Tb.Th, Tb.N and Tb.Sp in indicated groups, n = 10. (J) Representative µCT images about 2D images of longitudinal section tibias and 3D images of proximal tibias. The coloring parts represent the ROI for analysis. Quantification of tibial BMD, BV/TV, Tb.Th, Tb.N and Tb.Sp in indicated groups, n = 10. (*p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001, N.S represented not significant)

    Journal: Journal of nanobiotechnology

    Article Title: Gold nanoparticles exhibit anti-osteoarthritic effects via modulating interaction of the "microbiota-gut-joint" axis.

    doi: 10.1186/s12951-024-02447-y

    Figure Lengend Snippet: Fig. 3 The protective effect of GNPs against ACLT-induced OA disappeared after gut microbiota consumption. (A) The schematic diagram of gut micro biota consumption experiments. (B) H&E, Safranine O and Toluidine Blue staining of femur articular cartilage in ACLTVehicle+ABX and ACLTGNPs+ABX groups. (C) Immunohistochemical staining of the expression of MMP-13 in articular cartilage of sections. (D) Immunohistochemical staining of the expression of Ag grecan in articular cartilage of sections. (E) Quantitative analysis of OARSI histology scoring. (F) Quantitative analysis of MANKIN grading. (G) Quantitative analysis of percentage of cells with positive staining for MMP-13 in articular cartilage. (H) Quantitative analysis of percentage of cells with positive staining for Aggrecan in articular cartilage. (I) Representative µCT images about 2D images of longitudinal section femurs and 3D images of distal femurs. The col oring parts represent the ROI for analysis. Quantification of femoral BMD, BV/TV, Tb.Th, Tb.N and Tb.Sp in indicated groups, n = 10. (J) Representative µCT images about 2D images of longitudinal section tibias and 3D images of proximal tibias. The coloring parts represent the ROI for analysis. Quantification of tibial BMD, BV/TV, Tb.Th, Tb.N and Tb.Sp in indicated groups, n = 10. (*p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001, N.S represented not significant)

    Article Snippet: The subchondral bone regions of the distal femur and proximal tibia were selected as the region of interest (ROI), and 3D model visualization software (CTvox, Bruker micro-CT, ver.3.3.1.0) was used for 3-dimensional histomorphometric analysis.

    Techniques: Staining, Immunohistochemical staining, Expressing

    Fig. 4 Fecal microbiota transplantation alleviated ACLT-induced OA. (A) The schematic diagram of the FMT experiments. (B) H&E, Safranine O and Tolu idine Blue staining of femur articular cartilage in ACLTVehicle+FMT and ACLTGNPs+FMT group. (C) Immunohistochemical staining of the expression of MMP- 13 in articular cartilage of sections. (D) Immunohistochemical staining of the expression of Aggrecan in articular cartilage of sections. (E) Quantitative analysis of OARSI histology scoring. (F) Quantitative analysis of MANKIN grading. (G) Quantitative analysis of percentage of cells with positive staining for MMP-13 in articular cartilage. (H) Quantitative analysis of percentage of cells with positive staining for Aggrecan in articular cartilage. (I) Representative µCT images about 2D images of longitudinal section femurs and 3D images of distal femurs. The coloring parts represent the ROI for analysis. Quantifica tion of femoral BMD, BV/TV, Tb.Th, Tb.N and Tb.Sp in indicated groups, n = 5. (J) Representative µCT images about 2D images of longitudinal section tibias and 3D images of proximal tibias. The coloring parts represent the ROI for analysis. Quantification of tibial BMD, BV/TV, Tb.Th, Tb.N and Tb.Sp in indicated groups, n = 5. (*p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001, N.S represented not significant)

    Journal: Journal of nanobiotechnology

    Article Title: Gold nanoparticles exhibit anti-osteoarthritic effects via modulating interaction of the "microbiota-gut-joint" axis.

    doi: 10.1186/s12951-024-02447-y

    Figure Lengend Snippet: Fig. 4 Fecal microbiota transplantation alleviated ACLT-induced OA. (A) The schematic diagram of the FMT experiments. (B) H&E, Safranine O and Tolu idine Blue staining of femur articular cartilage in ACLTVehicle+FMT and ACLTGNPs+FMT group. (C) Immunohistochemical staining of the expression of MMP- 13 in articular cartilage of sections. (D) Immunohistochemical staining of the expression of Aggrecan in articular cartilage of sections. (E) Quantitative analysis of OARSI histology scoring. (F) Quantitative analysis of MANKIN grading. (G) Quantitative analysis of percentage of cells with positive staining for MMP-13 in articular cartilage. (H) Quantitative analysis of percentage of cells with positive staining for Aggrecan in articular cartilage. (I) Representative µCT images about 2D images of longitudinal section femurs and 3D images of distal femurs. The coloring parts represent the ROI for analysis. Quantifica tion of femoral BMD, BV/TV, Tb.Th, Tb.N and Tb.Sp in indicated groups, n = 5. (J) Representative µCT images about 2D images of longitudinal section tibias and 3D images of proximal tibias. The coloring parts represent the ROI for analysis. Quantification of tibial BMD, BV/TV, Tb.Th, Tb.N and Tb.Sp in indicated groups, n = 5. (*p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001, N.S represented not significant)

    Article Snippet: The subchondral bone regions of the distal femur and proximal tibia were selected as the region of interest (ROI), and 3D model visualization software (CTvox, Bruker micro-CT, ver.3.3.1.0) was used for 3-dimensional histomorphometric analysis.

    Techniques: Transplantation Assay, Staining, Immunohistochemical staining, Expressing